About the Lab
The Endocrine, Metabolic and Reproductive Advancements (EMBRACE) Women’s Health Research Lab at the University of Calgary in Calgary, Canada aims to enhance reproductive and cardiometabolic health across the life course in individuals affected by reproductive endocrine disorders, such as polycystic ovary syndrome (PCOS) and gestational diabetes.
Our Research
Our team is at the forefront of women’s health research. Through innovative studies, we aim to uncover new diagnostic tools, treatments, and preventative measures.
Throughout the research process, we work closely with people with lived experience and experts from related clinical and research fields.
By participating in or donating to our research program, you are helping to shape the future of women’s health care.
Participate in Our Research
Are you interested in participating our studies? Let’s start a conversation.
Collaborators
For researchers, institutions, journalists & publications that wish to collaborate with our team on future & ongoing studies.
Lab News

August 22nd, 2025
On August 22nd, 2025 we were pleased to be a part of the 2025 Libin Summer...

August 12, 2025
We were delighted to welcome a High School Youth Researcher Summer (HYRS) student to our lab...

July 17, 2025
A new article titled “Polycystic ovary syndrome (PCOS) is a big threat to women’s health, but...
Latest Publications
Validity of administrative health data case definitions for identifying polycystic ovary syndrome: a systematic review and meta-analysis.
Hu S, Lalonde-Bester S, Salem J, Koshy S, Vine D, Harrison TG, Yamamoto JM, Benham JL. Hum Reprod. 2025. Online ahead of print. PMID: 40381996
Virtual vs. in-person care in gestational diabetes management: a retrospective cohort analysis
Dolatabadi S, Yamamoto JM, Brennand EA, Donovan LE, Benham JL.
Uptake and factors associated with COVID-19 vaccination among 3,779,733 adults living with and without diabetes: a population cohort study in a universal healthcare setting
Butalia S, Sigal RJ, Shah BR, Benham JL, Wicklow B, Yu CH, Dasgupta K, Chu LM, Amed S, Constantinescu C, Kaul P. Can J Diabetes. 2025.
Gestational diabetes laboratory testing in Alberta before and during the COVID-19 pandemic
Benham JL, Stephenson N, Metcalfe A, Donovan LE, Feig DS, Pylypjuk C, Ruth C, Berger H, Sigurdson SM, Shah BR, Yamamoto JM. Can J Diabetes. 2025.
Impact of bariatric surgery on anthropometric, metabolic, and reproductive outcomes in polycystic ovary syndrome: a systematic review and meta-analysis
Benham JL, Corbett KS, Yamamoto JM, McClurg C, Piltonen T, Yildiz BO, Li R, Mousa A, Tay CT, Spritzer PM, Teede H, Boyle JA, Brown WA. Obesity Reviews. 2024;25(6):e13737.
Polycystic ovary syndrome and type 1 diabetes in pregnancy
Dolatabadi S, Yamamoto JM, Benham JL. J Obstet Gynaecol Can. 2024;46(5):102363.